133 related articles for article (PubMed ID: 11136299)
1. The intracellular activation of lamivudine (3TC) and determination of 2'-deoxycytidine-5'-triphosphate (dCTP) pools in the presence and absence of various drugs in HepG2 cells.
Kewn S; Hoggard PG; Sales SD; Johnson MA; Back DJ
Br J Clin Pharmacol; 2000 Dec; 50(6):597-604. PubMed ID: 11136299
[TBL] [Abstract][Full Text] [Related]
2. Molecular modeling and biochemical characterization reveal the mechanism of hepatitis B virus polymerase resistance to lamivudine (3TC) and emtricitabine (FTC).
Das K; Xiong X; Yang H; Westland CE; Gibbs CS; Sarafianos SG; Arnold E
J Virol; 2001 May; 75(10):4771-9. PubMed ID: 11312349
[TBL] [Abstract][Full Text] [Related]
3. Lamivudine (3TC) phosphorylation and drug interactions in vitro.
Kewn S; Veal GJ; Hoggard PG; Barry MG; Back DJ
Biochem Pharmacol; 1997 Sep; 54(5):589-95. PubMed ID: 9337075
[TBL] [Abstract][Full Text] [Related]
4. Effect of mycophenolate mofetil on the pharmacokinetics of antiretroviral drugs and on intracellular nucleoside triphosphate pools.
Sankatsing SU; Hoggard PG; Huitema AD; Sparidans RW; Kewn S; Crommentuyn KM; Lange JM; Beijnen JH; Back DJ; Prins JM
Clin Pharmacokinet; 2004; 43(12):823-32. PubMed ID: 15355127
[TBL] [Abstract][Full Text] [Related]
5. Increased activation of the combination of 3'-azido-3'-deoxythymidine and 2'-deoxy-3'-thiacytidine in the presence of hydroxyurea.
Palmer S; Cox S
Antimicrob Agents Chemother; 1997 Feb; 41(2):460-4. PubMed ID: 9021208
[TBL] [Abstract][Full Text] [Related]
6. Intracellular activation of 2',3'-dideoxyinosine and drug interactions in vitro.
Kewn S; Hoggard PG; Henry-Mowatt JS; Veal GJ; Sales SD; Barry MG; Back DJ
AIDS Res Hum Retroviruses; 1999 Jun; 15(9):793-802. PubMed ID: 10381167
[TBL] [Abstract][Full Text] [Related]
7. Perspectives on the molecular mechanism of inhibition and toxicity of nucleoside analogs that target HIV-1 reverse transcriptase.
Anderson KS
Biochim Biophys Acta; 2002 Jul; 1587(2-3):296-9. PubMed ID: 12084471
[TBL] [Abstract][Full Text] [Related]
8. Modulation of the metabolism of beta-L-(-)-2',3'-dideoxy-3'-thiacytidine by thymidine, fludarabine, and nitrobenzylthioinosine.
Rahn JJ; Kieller DM; Tyrrell DL; Gati WP
Antimicrob Agents Chemother; 1997 May; 41(5):918-23. PubMed ID: 9145844
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic studies comparing the incorporation of (+) and (-) isomers of 3TCTP by HIV-1 reverse transcriptase.
Feng JY; Anderson KS
Biochemistry; 1999 Jan; 38(1):55-63. PubMed ID: 9890882
[TBL] [Abstract][Full Text] [Related]
10. The effect of hydroxyurea on the phosphorylation of zidovudine and lamivudine in human umbilical vein endothelial cells.
McGuire TR; Hoie EB; Manouilov KK; Gwilt PG
In Vitro Cell Dev Biol Anim; 2003; 39(7):280-2. PubMed ID: 14572303
[TBL] [Abstract][Full Text] [Related]
11. Insights into the molecular mechanism of mitochondrial toxicity by AIDS drugs.
Feng JY; Johnson AA; Johnson KA; Anderson KS
J Biol Chem; 2001 Jun; 276(26):23832-7. PubMed ID: 11328813
[TBL] [Abstract][Full Text] [Related]
12. Concentrations of zidovudine- and lamivudine-triphosphate according to cell type in HIV-seronegative adults.
Anderson PL; Zheng JH; King T; Bushman LR; Predhomme J; Meditz A; Gerber J; Fletcher CV
AIDS; 2007 Sep; 21(14):1849-54. PubMed ID: 17721092
[TBL] [Abstract][Full Text] [Related]
13. YADD mutants of human immunodeficiency virus type 1 and Moloney murine leukemia virus reverse transcriptase are resistant to lamivudine triphosphate (3TCTP) in vitro.
Boyer PL; Gao HQ; Clark PK; Sarafianos SG; Arnold E; Hughes SH
J Virol; 2001 Jul; 75(14):6321-8. PubMed ID: 11413298
[TBL] [Abstract][Full Text] [Related]
14. The role of steric hindrance in 3TC resistance of human immunodeficiency virus type-1 reverse transcriptase.
Gao HQ; Boyer PL; Sarafianos SG; Arnold E; Hughes SH
J Mol Biol; 2000 Jul; 300(2):403-18. PubMed ID: 10873473
[TBL] [Abstract][Full Text] [Related]
15. Time-dependent changes in HIV nucleoside analogue phosphorylation and the effect of hydroxyurea.
Hoggard PG; Kewn S; Maherbe A; Wood R; Almond LM; Sales SD; Gould J; Lou Y; De Vries C; Back DJ; Khoo SH;
AIDS; 2002 Dec; 16(18):2439-46. PubMed ID: 12461418
[TBL] [Abstract][Full Text] [Related]
16. NDP kinase reactivity towards 3TC nucleotides.
Kreimeyer A; Schneider B; Sarfati R; Faraj A; Sommadossi JP; Veron M; Deville-Bonne D
Antiviral Res; 2001 May; 50(2):147-56. PubMed ID: 11369435
[TBL] [Abstract][Full Text] [Related]
17. Anti-hepatitis B virus activity and metabolism of 2',3'-dideoxy-2',3'-didehydro-beta-L(-)-5-fluorocytidine.
Zhu YL; Dutschman DE; Liu SH; Bridges EG; Cheng YC
Antimicrob Agents Chemother; 1998 Jul; 42(7):1805-10. PubMed ID: 9661025
[TBL] [Abstract][Full Text] [Related]
18. Intracellular nucleoside triphosphate concentrations in HIV-infected patients on dual nucleoside reverse transcriptase inhibitor therapy.
Moore JD; Acosta EP; Johnson VA; Bassett R; Eron JJ; Fischl MA; Long MC; Kuritzkes DR; Sommadossi JP
Antivir Ther; 2007; 12(6):981-6. PubMed ID: 17926654
[TBL] [Abstract][Full Text] [Related]
19. 2',3'-Dideoxycytidine toxicity in cultured human CEM T lymphoblasts: effects of combination with 3'-azido-3'-deoxythymidine and thymidine.
Törnevik Y; Eriksson S
Mol Pharmacol; 1990 Aug; 38(2):237-43. PubMed ID: 2166904
[TBL] [Abstract][Full Text] [Related]
20. Development of enzymatic assays for quantification of intracellular lamivudine and carbovir triphosphate levels in peripheral blood mononuclear cells from human immunodeficiency virus-infected patients.
Kewn S; Hoggard PG; Sales SD; Jones K; Maher B; Khoo SH; Back DJ
Antimicrob Agents Chemother; 2002 Jan; 46(1):135-43. PubMed ID: 11751124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
